Drug-labels.com

Odan-Phenylephrine Product Monograph

Status:
Over-the-counter (OTC) Current status: Dormant Facts
Strength:
2.5 %
Active ingredient:

Product Monograph - Odan-Phenylephrine

ADVERSE EFFECTS

It is well to bear in mind that phenylephrine is, in fact, a sympathomimetic drug related to epinephrine and ephedrine, and that although the incidence is rare, it may produce such reactions as tremor, pallor, perspiration, palpitation or collapse.

DOSAGE AND ADMINISTRATION

Topically, 1 or 2 drops into the conjunctiva of each eye for refraction, in conjunction with the cycloplegic of choice, and ophthalmoscopic examination. ODAN-PHENYLEPHRINE may be applied topically from 30 to 60 minutes prior to surgery.

AVAILABILITY

Each mL of sterile ophthalmic solution contains 25 mg Phenylephrine Hydrochloride USP and the following non-medicinal ingredients: boric acid, dibasic and monobasic sodium phosphate, water, and pH adjusted with phosphoric acid and/or sodium hydroxide. Contains benzalkonium chloride 0.01% as preservative. Available in 15 mL plastic squeeze bottles with dropper tip.

STORAGE CONDITIONS

Keep container tightly closed. Store between 2°C and 30°C, protect from light.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00622915

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Odan-Phenylephrine

Rx or OTC
Over-the-counter (OTC)?
DIN 00622915
Schedule(s) NON-PRESCRIPTION DRUGS
Active ingredient(s) Phenylephrine hydrochloride 2.5 %
Dosage form(s) Solution
Route(s) of administration Ophthalmic
Drug class (WHO ATC)
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01F Mydriatics and cycloplegics
        1. S01FB Sympathomimetics excl. antiglaucoma preparations
          1. S01FB01 Phenylephrine
Company ODAN LABORATORIESLTD
Current status Dormant
Current status date June 22, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.